President Trump is expected to nominate Dr. Heidi Overton to serve as the next Food and Drug Administration commissioner. Overton, a physician and White House domestic policy aide who regularly briefs Trump on health matters, recently stood by his side when he announced an executive order to reduce recommended childhood vaccinations.

During that event, Dr. Overton stated the order would help states recognize “gold standard” vaccination recommendations and take steps to limit vaccines required for school entry. She emphasized working directly with states to avoid relying on court cases to resolve vaccine-related disputes, saying: “We are doing it right away so that parents get the benefit from state laws changing.”

Currently serving as deputy assistant to the president for domestic policy, Overton previously held leadership roles at the America First Policy Institute, a conservative think tank. She has authored pieces denouncing abortion as “corrosive” to women and advocated for stricter controls over abortion pill prescriptions, describing them as “far more dangerous to women.”

In September, Overton and Calley Means collaborated on a MAHA strategy report urging additional reviews of chemicals in food and expanded oversight of pharmaceutical advertising. Overton reiterated during the report that states adopting the “gold standard” childhood vaccine recommendations would align parents with European practices when enrolling children in schools.

Overton holds board certification in public health and general preventive medicine, completed her surgical residency at Johns Hopkins Hospital in Baltimore, and earned a doctorate in clinical investigation there. Her selection follows decades of appointing medical doctors to the FDA leadership role.

The nominee is currently set to undergo Senate confirmation before assuming the position. She crossed paths with former FDA Commissioner Marty Makary during their time at Johns Hopkins, where they co-wrote a 2017 op-ed linking surgeons’ prescribing practices to the opioid crisis. Makary led the agency from March 2025 until his removal in May. Kyle Diamantas, who now acts as interim commissioner and has ties to Donald Trump Jr., previously managed the FDA’s food division.